- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Long the bastion of the fabulously rich, these firms are no longer letting others do their bidding and are instead directly investing in portfolio companies themselves.
The deal comes as Abbott works to complete two pending transactions worth nearly $40 billion combined and is the latest in the slew of ophthalmology deals.
Here are Friday's top research calls, including downgrades for Citigroup and Novavax, an upgrade Comerica and new coverage of PepsiCo.